

The FDA has approved the Apple Watch's atrial fibrillation history feature as a Medical Device Development Tool, marking it as the first digital health technology to qualify for use in clinical trials. This feature allows users to monitor the frequency of irregular heart rhythms, providing valuable data for clinical studies. The approval highlights the Apple Watch's potential in medical research, particularly in understanding and managing arrhythmias.